{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:53:07Z","timestamp":1782521587311,"version":"3.54.5"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T00:00:00Z","timestamp":1648425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T00:00:00Z","timestamp":1648425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>There is currently no consensus on the key outcomes of reproductive genetic carrier screening (RGCS). This has led to a large amount of variability in approaches to research, limiting direct comparison and synthesis of findings. In a recently published systematic review of quantitative studies on RGCS, we found that few studies incorporated patient-reported outcomes. In response to this gap, we conducted a sequential systematic review of qualitative studies to identify outcomes exploring the patient experience of RGCS. In conjunction with the review of quantitative studies, these outcomes will be used to inform the development of a core outcome set. Text excerpts relevant to outcomes, including quotes and themes, were extracted verbatim and deductively coded as outcomes. We conducted a narrative synthesis to group outcomes within domains previously defined in our review of quantitative studies, and identify any new domains that were unique to qualitative studies. Seventy-eight outcomes were derived from qualitative studies and grouped into 19 outcome domains. Three new outcome domains were identified; \u2018goals of pre- and post-test genetic counselling\u2019, \u2018acceptability of further testing and alternative reproductive options\u2019, and \u2018perceived utility of RGCS\u2019. The identification of outcome domains that were not identified in quantitative studies indicates that outcomes reflecting the patient perspective may be under-represented in the quantitative literature on this topic. Further work should focus on ensuring that outcomes reflect the real world needs and concerns of patients in order to maximise translation of research findings into clinical practice.<\/jats:p>","DOI":"10.1038\/s41431-022-01090-1","type":"journal-article","created":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T13:04:13Z","timestamp":1648472653000},"page":"756-765","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Incorporating patient perspectives in the development of a core outcome set for reproductive genetic carrier screening: a sequential systematic review"],"prefix":"10.1038","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4260-7356","authenticated-orcid":false,"given":"Ebony","family":"Richardson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"McEwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toby","family":"Newton-John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5578-0460","authenticated-orcid":false,"given":"Ashley","family":"Crook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9557-9080","authenticated-orcid":false,"given":"Chris","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,28]]},"reference":[{"key":"1090_CR1","unstructured":"Genomics Advisory Working Group & Women\u2019s Health Committee. Genetic carrier screening. RANZCOG; 2019."},{"key":"1090_CR2","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1038\/s41436-021-01203-z","volume":"23","author":"AR Gregg","year":"2021","unstructured":"Gregg AR, Aarabi M, Klugman S, Leach NT, Bashford MT, Goldwaser T, et al. Screening for autosomal recessive and X-linked conditions during pregnancy and preconception: a practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2021;23:1793\u2013806.","journal-title":"Genet Med"},{"key":"1090_CR3","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.jogc.2016.06.008","volume":"38","author":"RD Wilson","year":"2016","unstructured":"Wilson RD, De Bie I, Armour CM, Brown RN, Campagnolo C, Carroll JC, et al. Joint SOGC-CCMG opinion for reproductive genetic carrier screening: an update for all Canadian providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing. J Obstet Gynaecol Can. 2016;38:742\u201362 e3.","journal-title":"J Obstet Gynaecol Can"},{"key":"1090_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-021-05439-7","volume":"22","author":"E Richardson","year":"2021","unstructured":"Richardson E, McEwen A, Newton-John T, Manera K, Jacobs C. The Core Outcome DEvelopment for Carrier Screening (CODECS) study: protocol for development of a core outcome set. Trials. 2021;22:480.","journal-title":"Trials"},{"key":"1090_CR5","doi-asserted-by":"crossref","unstructured":"Richardson E, McEwen A, Newton-John T, Crook A, Jacobs C. Systematic review of outcomes in studies of reproductive genetic carrier screening: Towards development of a core outcome set. Genetics in Medicine. 2021;24:1\u201314.","DOI":"10.1016\/j.gim.2021.08.005"},{"key":"1090_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-017-1978-4","volume":"18","author":"PR Williamson","year":"2017","unstructured":"Williamson PR, Altman DG, Bagley H, Barnes KL, Blazeby JM, Brookes ST, et al. The COMET Handbook: Version 1.0. Trials. 2017;18:280.","journal-title":"Trials"},{"key":"1090_CR7","doi-asserted-by":"publisher","first-page":"e1002447","DOI":"10.1371\/journal.pmed.1002447","volume":"14","author":"JJ Kirkham","year":"2017","unstructured":"Kirkham JJ, Davis K, Altman DG, Blazeby JM, Clarke M, Tunis S, et al. Core Outcome Set-STAndards for Development: The COS-STAD recommendations. PLoS Med. 2017;14:e1002447.","journal-title":"PLoS Med"},{"key":"1090_CR8","doi-asserted-by":"crossref","unstructured":"de Wit M, Abma T, Koelewijn-van Loon M, Collins S, Kirwan J Involving patient research partners has a significant impact on outcomes research: a responsive evaluation of the international OMERACT conferences. BMJ Open. 2013;3:e002241.","DOI":"10.1136\/bmjopen-2012-002241"},{"key":"1090_CR9","doi-asserted-by":"publisher","first-page":"e000615","DOI":"10.1136\/bmjdrc-2018-000615","volume":"7","author":"SL Gorst","year":"2019","unstructured":"Gorst SL, Young B, Williamson PR, Wilding JPH, Harman NL. Incorporating patients\u2019 perspectives into the initial stages of core outcome set development: a rapid review of qualitative studies of type 2 diabetes. BMJ Open Diabetes Res Care. 2019;7:e000615.","journal-title":"BMJ Open Diabetes Res Care"},{"key":"1090_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-016-1356-7","volume":"17","author":"T Keeley","year":"2016","unstructured":"Keeley T, Williamson P, Callery P, Jones LL, Mathers J, Jones J, et al. The use of qualitative methods to inform Delphi surveys in core outcome set development. Trials. 2016;17:230.","journal-title":"Trials"},{"key":"1090_CR11","first-page":"e123","volume":"3","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Open Med. 2009;3:e123\u201330.","journal-title":"Open Med"},{"key":"1090_CR12","unstructured":"Kmet LM, Cook LS, Lee RC. Standard quality assessment criteria for evaluating primary research papers from a variety of fields. Edmonton: Alberta Heritage Foundation for Medical Research; 2004."},{"key":"1090_CR13","unstructured":"QSR International Pty Ltd. NVivo (Version 12). Available from https:\/\/Www.Qsrinternational.Com\/Nvivo-Qualitative-Data-Analysis-Software\/Home. 2018."},{"key":"1090_CR14","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jclinepi.2017.12.020","volume":"96","author":"S Dodd","year":"2018","unstructured":"Dodd S, Clarke M, Becker L, Mavergames C, Fish R, Williamson PR. A taxonomy has been developed for outcomes in medical research to help improve knowledge discovery. J Clin Epidemiol. 2018;96:84\u201392.","journal-title":"J Clin Epidemiol"},{"key":"1090_CR15","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1002\/ajmg.a.37697","volume":"170","author":"CA Beard","year":"2016","unstructured":"Beard CA, Amor DJ, Di Pietro L, Archibald AD. \u201cI\u2019m Healthy, It\u2019s Not Going To Be Me\u201d: Exploring experiences of carriers identified through a population reproductive genetic carrier screening panel in Australia. Am J Med Genet A. 2016;170:2052\u20139.","journal-title":"Am J Med Genet A"},{"key":"1090_CR16","doi-asserted-by":"publisher","first-page":"e0200139","DOI":"10.1371\/journal.pone.0200139","volume":"13","author":"EV Clarke","year":"2018","unstructured":"Clarke EV, Schneider JL, Lynch F, Kauffman TL, Leo MC, Rosales AG, et al. Assessment of willingness to pay for expanded carrier screening among women and couples undergoing preconception carrier screening. PLoS ONE. 2018;13:e0200139.","journal-title":"PLoS ONE"},{"key":"1090_CR17","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s12687-012-0136-7","volume":"4","author":"NE Cousens","year":"2013","unstructured":"Cousens NE, Gaff CL, Metcalfe SA, Delatycki MB. \u201cHe didn\u2019t say that thalassaemia might come up\u201d - beta-thalassaemia carriers\u2019 experiences and attitudes. J Community Genet. 2013;4:223\u201332.","journal-title":"J Community Genet"},{"key":"1090_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta14200","volume":"14","author":"E Dormandy","year":"2010","unstructured":"Dormandy E, Bryan S, Gulliford MC, Roberts TE, Ades AE, Calnan M, et al. Antenatal screening for haemoglobinopathies in primary care: a cohort study and cluster randomised trial to inform a simulation model. The Screening for Haemoglobinopathies in First Trimester (SHIFT) trial. Health Technol Assess. 2010;14:1\u2013160.","journal-title":"Health Technol Assess"},{"key":"1090_CR19","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/j.socscimed.2011.09.031","volume":"73","author":"A Frumkin","year":"2011","unstructured":"Frumkin A, Raz AE, Plesser-Duvdevani M, Lieberman S. \u201cThe Most Important Test You\u2019ll Ever Take\u201d?: attitudes toward confidential carrier matching and open individual testing among modern-religious Jews in Israel. Soc Sci Med. 2011;73:1741\u20137.","journal-title":"Soc Sci Med"},{"key":"1090_CR20","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s12687-018-0388-y","volume":"10","author":"KCA Holtkamp","year":"2019","unstructured":"Holtkamp KCA, Henneman L, Gille JJP, Meijers-Heijboer H, Cornel MC, Lakeman P. Direct-to-consumer carrier screening for cystic fibrosis via a hospital website: a 6-year evaluation. J Community Genet. 2019;10:249\u201357.","journal-title":"J Community Genet"},{"key":"1090_CR21","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s10897-017-0159-7","volume":"27","author":"KCA Holtkamp","year":"2018","unstructured":"Holtkamp KCA, Lakeman P, Hader H, Jans S, Hoenderdos M, Playfair HAM, et al. Experiences of a high-risk population with prenatal hemoglobinopathy carrier screening in a primary care setting: a qualitative study. J Genet Couns. 2018;27:635\u201346.","journal-title":"J Genet Couns"},{"key":"1090_CR22","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s10897-015-9833-9","volume":"24","author":"L Ioannou","year":"2015","unstructured":"Ioannou L, Delatycki MB, Massie J, Hodgson J, Lewis S. \u201cSuddenly having two positive people who are carriers is a whole new thing\u201d - Experiences of couples both identified as carriers of cystic fibrosis through a population-based carrier screening program in Australia. J Genet Couns. 2015;24:987\u20131000.","journal-title":"J Genet Couns"},{"key":"1090_CR23","first-page":"1","volume":"2","author":"AL Kalfoglou","year":"2011","unstructured":"Kalfoglou AL, Broder M. Orthodox Ashkenazi young adults\u2019 knowledge, experiences, attitudes, and beliefs about Genetic Carrier Testing. AJOB Primary. Research. 2011;2:1\u20137.","journal-title":"Research"},{"key":"1090_CR24","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/ajmg.a.38583","volume":"176","author":"SA Kraft","year":"2018","unstructured":"Kraft SA, McMullen CK, Porter KM, Kauffman TL, Davis JV, Schneider JL, et al. Patient perspectives on the use of categories of conditions for decision making about genomic carrier screening results. Am J Med Genet A. 2018;176:376\u201385.","journal-title":"Am J Med Genet A"},{"key":"1090_CR25","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1111\/cge.13206","volume":"93","author":"SA Kraft","year":"2018","unstructured":"Kraft SA, Schneider JL, Leo MC, Kauffman TL, Davis JV, Porter KM, et al. Patient actions and reactions after receiving negative results from expanded carrier screening. Clin Genet. 2018;93:962\u201371.","journal-title":"Clin Genet"},{"key":"1090_CR26","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1177\/1359105311417193","volume":"17","author":"C Lewis","year":"2012","unstructured":"Lewis C, Skirton H, Jones R. Reproductive empowerment: the main motivator and outcome of carrier testing. J Health Psychol. 2012;17:567\u201378.","journal-title":"J Health Psychol"},{"key":"1090_CR27","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41431-017-0056-4","volume":"26","author":"IB Mathijssen","year":"2018","unstructured":"Mathijssen IB, Holtkamp KCA, Ottenheim CPE, van Eeten-Nijman JMC, Lakeman P, Meijers-Heijboer H, et al. Preconception carrier screening for multiple disorders: evaluation of a screening offer in a Dutch founder population. Eur J Hum Genet. 2018;26:166\u201375.","journal-title":"Eur J Hum Genet"},{"key":"1090_CR28","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1007\/s10897-016-0037-8","volume":"26","author":"E Rothwell","year":"2017","unstructured":"Rothwell E, Johnson E, Mathiesen A, Golden K, Metcalf A, Rose NC, et al. Experiences among women with positive prenatal expanded carrier screening results. J Genet Couns. 2017;26:690\u20136.","journal-title":"J Genet Couns"},{"key":"1090_CR29","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/pd.5055","volume":"38","author":"J Tardif","year":"2018","unstructured":"Tardif J, Pratte A, Laberge AM. Experience of carrier couples identified through a population-based carrier screening pilot program for four founder autosomal recessive diseases in Saguenay-Lac-Saint-Jean. Prenat Diagn. 2018;38:67\u201374.","journal-title":"Prenat Diagn"},{"key":"1090_CR30","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.1369-7625.2011.00669.x","volume":"15","author":"V Tsianakas","year":"2012","unstructured":"Tsianakas V, Atkin K, Calnan MW, Dormandy E, Marteau TM. Offering antenatal sickle cell and thalassaemia screening to pregnant women in primary care: a qualitative study of women\u2019s experiences and expectations of participation. Health Expect. 2012;15:115\u201325.","journal-title":"Health Expect"},{"key":"1090_CR31","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10897-005-9014-3","volume":"15","author":"R Resta","year":"2006","unstructured":"National Society of Genetic Counselors\u2019 Definition Task F, Resta R, Biesecker BB, Bennett RL, Blum S, Hahn SE, et al. A new definition of Genetic Counseling: National Society of Genetic Counselors\u2019 Task Force report. J Genet Couns. 2006;15:77\u201383.","journal-title":"J Genet Couns"},{"key":"1090_CR32","unstructured":"Human Genetics Society of Australasia. Guideline: Process of Genetic Counselling. 2015."},{"key":"1090_CR33","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/00125817-200207000-00002","volume":"4","author":"L Henneman","year":"2002","unstructured":"Henneman L, Poppelaars FA, ten Kate LP. Evaluation of cystic fibrosis carrier screening programs according to genetic screening criteria. Genet Med. 2002;4:241\u20139.","journal-title":"Genet Med"},{"key":"1090_CR34","unstructured":"Wilson JMG, Jungner G. Principles and Practice of Screening for Disease. Geneva: World Health Organization. 1968. Available from: http:\/\/apps.who.int\/iris\/bitstream\/10665\/37650\/17\/WHO_PHP_34.pdf"},{"key":"1090_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-017-2031-8","volume":"17","author":"M Sekhon","year":"2017","unstructured":"Sekhon M, Cartwright M, Francis JJ. Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework. BMC Health Serv Res. 2017;17:88.","journal-title":"BMC Health Serv Res"},{"key":"1090_CR36","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1038\/ejhg.2015.271","volume":"24","author":"L Henneman","year":"2016","unstructured":"Henneman L, Borry P, Chokoshvili D, Cornel MC, van El CG, Forzano F, et al. Responsible implementation of expanded carrier screening. Eur J Hum Genet. 2016;24:e1\u201312.","journal-title":"Eur J Hum Genet"},{"key":"1090_CR37","doi-asserted-by":"publisher","first-page":"165","DOI":"10.5694\/mja2.50789","volume":"214","author":"L Dive","year":"2021","unstructured":"Dive L, Newson AJ. Ethical issues in reproductive genetic carrier screening. Med J Aust. 2021;214:165\u20137 e1.","journal-title":"Med J Aust"},{"key":"1090_CR38","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/j.1552-6909.1998.tb02621.x","volume":"27","author":"MH Hutti","year":"1998","unstructured":"Hutti MH, dePacheco M, Smith M. A study of miscarriage: development and validation of the Perinatal Grief Intensity Scale. J Obstet Gynecol Neonatal Nurs. 1998;27:547\u201355.","journal-title":"J Obstet Gynecol Neonatal Nurs"},{"key":"1090_CR39","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1136\/jme.2005.013532","volume":"32","author":"MW Foster","year":"2006","unstructured":"Foster MW, Royal C, Sharp R. The routinisation of genomics and genetics: implications for ethical practices. J Med Ethics. 2006;32:635\u20138.","journal-title":"J Med Ethics"},{"key":"1090_CR40","unstructured":"van der Meij KR, Njio A, Martin L, Gitsels-van der Wal JT, Bekker MN, van Vliet-Lachotzki EH, et al. Routinization of prenatal screening with the non-invasive prenatal test: Pregnant women\u2019s perspectives. Eur J Hum Genet. 2021:1\u20138. https:\/\/www.nature.com\/articles\/s41431-021-00940-8."},{"key":"1090_CR41","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1136\/medethics-2017-104729","volume":"44","author":"A Kater-Kuipers","year":"2018","unstructured":"Kater-Kuipers A, de Beaufort ID, Galjaard R-JH, Bunnik EM. Ethics of routine: a critical analysis of the concept of \u2018routinisation\u2019in prenatal screening. J Med Ethics. 2018;44:626\u201331.","journal-title":"J Med Ethics"},{"key":"1090_CR42","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1177\/0890334419830990","volume":"35","author":"JE Dodgson","year":"2019","unstructured":"Dodgson JE. Reflexivity in qualitative research. J Hum Lactation. 2019;35:220\u20132.","journal-title":"J Hum Lactation"},{"key":"1090_CR43","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/swr\/svu028","volume":"39","author":"B Probst","year":"2015","unstructured":"Probst B. The eye regards itself: benefits and challenges of reflexivity in qualitative social work research. Soc Work Res. 2015;39:37\u201348.","journal-title":"Soc Work Res"},{"key":"1090_CR44","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19:349\u201357.","journal-title":"Int J Qual Health Care"},{"key":"1090_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-017-1870-2","volume":"18","author":"C Heneghan","year":"2017","unstructured":"Heneghan C, Goldacre B, Mahtani KR. Why clinical trial outcomes fail to translate into benefits for patients. Trials. 2017;18:122.","journal-title":"Trials"},{"key":"1090_CR46","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.1399-0004.2011.01636.x","volume":"79","author":"M McAllister","year":"2011","unstructured":"McAllister M, Wood AM, Dunn G, Shiloh S, Todd C. The Genetic Counseling Outcome Scale: a new patient-reported outcome measure for clinical genetics services. Clin Genet. 2011;79:413\u201324.","journal-title":"Clin Genet"},{"key":"1090_CR47","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1007\/s10897-017-0086-7","volume":"26","author":"BR Diness","year":"2017","unstructured":"Diness BR, Overbeck G, Hjortshoj TD, Hammer TB, Timshel S, Sorensen E, et al. Translation and Adaptation of the Genetic Counselling Outcome Scale (GCOS-24) for Use in Denmark. J Genet Couns. 2017;26:1080\u20139.","journal-title":"J Genet Couns"},{"key":"1090_CR48","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ejmg.2018.11.015","volume":"62","author":"PE Grant","year":"2019","unstructured":"Grant PE, Pampaka M, Payne K, Clarke A, McAllister M. Developing a short-form of the Genetic Counselling Outcome Scale: The Genomics Outcome Scale. Eur J Med Genet. 2019;62:324\u201334.","journal-title":"Eur J Med Genet"},{"key":"1090_CR49","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41431-018-0318-9","volume":"27","author":"JS Voorwinden","year":"2019","unstructured":"Voorwinden JS, Plantinga M, Krijnen W, Ausems M, Knoers N, Velthuizen M, et al. A validated PROM in genetic counselling: the psychometric properties of the Dutch version of the Genetic Counselling Outcome Scale. Eur J Hum Genet. 2019;27:681\u201390.","journal-title":"Eur J Hum Genet"}],"updated-by":[{"DOI":"10.1038\/s41431-022-01099-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T00:00:00Z","timestamp":1649980800000}}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-022-01090-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-022-01090-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-022-01090-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T23:07:02Z","timestamp":1657148822000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-022-01090-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,28]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["1090"],"URL":"https:\/\/doi.org\/10.1038\/s41431-022-01090-1","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41431-022-01099-6","asserted-by":"object"}]},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,28]]},"assertion":[{"value":"30 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2022","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41431-022-01099-6","URL":"https:\/\/doi.org\/10.1038\/s41431-022-01099-6","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}